APCB_Qld_TRIb_reduced

The QLD node of the APCB has relocated from the Institute of Health & Biomedical Innovation to the new Translational Research Institute (TRI) facility. TRI is positioned on campus at the Princess Alexandra Hospital, Queensland’s second largest hospital in Woolloongabba, Brisbane. Its physical environment facilitates its “bench to bedside” approach with 650+ researchers working within the architecturally designed building. The building has four floors for laboratory research and customised facilities for research support, administration and teaching. TRI is a joint venture between the University of Queensland’s Diamantina Institute, Queensland University of Technology’s Institute of Health & Biomedical Innovation, Mater Research and the Princess Alexandra Hospital’s Centres for Health Research and has been made possible through $354 million in funding provided by the Australian and Queensland Governments, The Atlantic Philanthropies, UQ and QUT.…

The APCB is expanding its collection in Queensland to include metastatic samples from men who have advanced prostate cancer and have donated their bodies to the Queensland University of Technology’s Body Bequest Program. A partnership has been established with this program and the Australian Prostate Cancer Research Centre-Qld to obtain high quality metastatic soft tissue and bone samples.

It is a unique opportunity to access metastatic samples which are difficult to obtain through other means and can only enhance the value of the APCB’s current collection.

To date four cases have been successfully consented and a wide range of tissues collected including fresh frozen and formalin fixed paraffin embedded (FFPE) soft tissue, bone (FFPE) and blood.

For more information on the program; either donating your body or accessing the samples for research please contact the QLD APCB Node Coordinator, Ms Allison Eckert, on (07) 3176 1891 or email allison.eckert@qut.edu.au.…

Rob_Sutherland-Current_thumb.jpg

It was with great sadness that the Australian prostate cancer biobanking and research community heard of Rob’s passing a year ago today. He was integral to the establishment of the Australian Prostate Cancer BioResource (APCB), which built considerably on his experience with the Garvan prostate cancer tissue bank, and was a key member of the national APCB Executive for 10 years.

His insight and sage advice on governance and operational issues, especially navigating the political minefield of the research funding scene, were always much appreciated. He was a generous and terrific man with whom we shared many a fine wine over the inevitable dinner to round off our deliberations! Rob’s leadership and generosity of spirit are sorely missed by his many friends & colleagues from the APCB.

Vale Rob.…